Get the Stockscreener App
0.3903
7.34%
0.0267
Silo Pharma Inc stock is traded at $0.3903, with a volume of 80,883.
It is up +7.34% in the last 24 hours and down -32.13% over the past month.
SILO Pharma Inc is a developmental stage biopharmaceutical company developing novel therapeutics that address underserved conditions including stress-induced psychiatric disorders, chronic pain conditions, and central nervous system (CNS) diseases. It focuses on developing traditional therapies and psychedelic treatments in novel formulations and drug delivery systems. The company's primary program, SPC-15, is an intranasal treatment targeting PTSD and stress-induced anxiety disorders.
See More
Previous Close:
$0.3636
Open:
$0.37
24h Volume:
80,883
Relative Volume:
0.07
Market Cap:
$5.20M
Revenue:
$72,100
Net Income/Loss:
$-3.60M
P/E Ratio:
-0.328
EPS:
-1.19
Net Cash Flow:
$-3.37M
1W Performance:
-5.54%
1M Performance:
-32.13%
6M Performance:
-12.39%
1Y Performance:
-57.11%
1-Day Range:
$0.3601
$0.3998
1-Week Range:
$0.3601
$0.47
52-Week Range:
$0.3601
$3.3699
Silo Pharma Inc Stock (SILO) Company Profile
Name
Silo Pharma Inc
Sector
Industry
Phone
(718) 400-9031
Address
677 N. WASHINGTON BLVD, SARASOTA
Compare SILO with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
SILO
SILO PHARMA INC
|
1.71 | 17.96M | 0 | 0 | 0 | 0.00 |
|
MOBBW
Mobilicom Limited Warrants
|
2.15 | 3.06B | 0 | 0 | 0 | 0.00 |
|
GOODO
Gladstone Commercial Corporation
|
19.51 | 372.90M | 0 | 0 | 0 | 0.00 |
|
SHMD
Schmid Group N V
|
4.15 | 166.65M | 0 | 0 | 0 | 0.00 |
|
PSNYW
Polestar Automotive Holding Uk
|
0.22 | 492.74M | 2.07B | -1.42B | -1.37B | -0.6765 |
|
DAVEW
Dave Inc
|
0.72 | 0 | 0 | 0 | 0 | 0.00 |
Silo Pharma Inc Stock (SILO) Latest News
Silo Pharma CEO Weisblum buys $735 in company stock By Investing.com - Investing.com Australia
[Form 4] Silo Pharma, Inc. Insider Trading Activity - Stock Titan
Silo Pharma CEO Weisblum buys $735 in company stock - Investing.com
Will earnings trigger a reversal in Silo Pharma Inc.Market Risk Report & Smart Investment Allocation Tips - newser.com
Is Silo Pharma Inc. stock attractive for long term wealth buildingEntry Point & Long-Term Safe Return Strategies - newser.com
Is now a turning point for Silo Pharma Inc.July 2025 Analyst Calls & Accurate Intraday Trade Tips - newser.com
Silo Pharma selects Allucent to support PTSD treatment IND submission By Investing.com - Investing.com Nigeria
Evaluating Silo Pharma Inc. with trendline analysisMarket Rally & Weekly Stock Performance Updates - newser.com
Silo Pharma selects Allucent to support PTSD treatment IND submission - investing.com
Silo Pharma partners with Allucent to support planned FDA Investigational New Drug application for SPC-15 as a therapeutic for PTSD - MarketScreener
Silo Pharma Partners With Allucent To Support Planned FDA Investigational New Drug Application For Spc-15 As A Therapeutic For Ptsd - TradingView
Silo Pharma (Nasdaq: SILO) taps Allucent to advance SPC-15 PTSD intranasal IND prep - Stock Titan
Can Silo Pharma Inc. stock deliver strong Q4 earningsNew Guidance & Free Safe Entry Trade Signal Reports - newser.com
Will Silo Pharma Inc. rebound enough to break evenExit Point & Weekly Watchlist for Hot Stocks - newser.com
Combining price and volume data for Silo Pharma Inc.July 2025 Trends & Consistent Profit Trade Alerts - newser.com
What drives Silo Pharma Inc stock priceInsider Buying Signals & Low Risk Capital Growth - earlytimes.in
[10-Q] Silo Pharma, Inc. Quarterly Earnings Report | SILO SEC FilingForm 10-Q - Stock Titan
Silo Pharma, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2025 - MarketScreener
What analysts say about Silo Pharma Inc stockEx-Dividend Date Alerts & Maximize ROI With Proven Growth Stocks - earlytimes.in
How strong is Silo Pharma Inc. stock revenue growthJuly 2025 Rallies & Real-Time Volume Analysis - newser.com
Silo Pharma announces pricing of $2 million public offering - MSN
Is Silo Pharma Inc. showing signs of accumulationEarnings Risk Report & Consistent Profit Focused Trading Strategies - newser.com
How analysts rate Silo Pharma Inc. stock todayTrade Ideas & Consistent Return Investment Signals - Fundação Cultural do Pará
Silo Pharma Inc Stock (SILO) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.38%
1.42%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):